Retapamulin
RxNorm 642274
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 642274 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: retapamulin.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing retapamulin (medicinal product)
(Atom ID: 9731410)
INPrescribable
Ingredient (IN):
Retapamulin
(Atom ID: 2655451)
PTPrescribable
Designated preferred name (PT):
Retapamulin
(Atom ID: 2723873)
FNPrescribable
Full form of descriptor (FN):
Retapamulin (substance)
(Atom ID: 2723875)
PTPrescribable
Designated preferred name (PT):
Retapamulin-containing product
(Atom ID: 10820233)
Patient Education
Retapamulin
Retapamulin is used to treat impetigo (a skin infection caused by bacteria) in children and adults. Retapamulin is in a class of medications called antibacterials. It works by killing and stopping the growth of bacteria on the skin.
[Learn More]
* Please review the disclaimer below.